On 24 January 2017
Biocon announced that a meeting of the Board of Directors of the Company will be held on 24 January 2017, inter alia, to consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter ended 31 December 2016 (Q3) amongst other routine matters.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
